April 09, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq ... today presented the design for the PPMP-enabled Phase 2 trial with volasertib, in combination with decitabine, in patients ...
Some results have been hidden because they may be inaccessible to you